Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).
CONCLUSIONS: Very low-quality evidence suggests there may be an effect of the use of bone marrow-derived stem cells in the healing of ulcers and improvement in the pain-free walking distance in patients with Buerger's disease. High-quality trials assessing the effectiveness of stem cell therapy for treatment of patients with thromboangiitis obliterans (Buerger's disease) are needed.
PMID: 30378681 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Cacione DG, do Carmo Novaes F, Moreno DH Tags: Cochrane Database Syst Rev Source Type: research
More News: Buerger's Disease | Clinical Trials | Databases & Libraries | General Medicine | International Medicine & Public Health | Pain | Pathology | Smokers | Stem Cell Therapy | Stem Cells | Study | WHO